IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

DSM Sets Ambitious Targets, Divests Citric Acid Business

8:42 AM MDT | October 4, 2010 | Natasha Alperowicz

DSM (Heerlen, the Netherlands) has updated financial targets to include sharply higher Ebitda and higher return on capital. The company also announced the sale of its citric acid business to Adcuram (Munich) and the formation of a joint venture with DuPont in surgical biomedical materials. DSM also plans to expand its biopharmaceutical joint venture with Crucell and is seeking partnerships for its anti-infectives business with companies in China and India. The company has set an Ebitda target of €1.4 billion-€1.6 billion ($1.9 billion-$2.1 billion) and return...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa